Endoglin, also known as CD105, is an endothelial cell membrane glycoprotein that is highly expressed in the neovascularization of cancer cells including HCC [154,155], which was first discovered in 1990s and initially named as the 44G4 antigen [156,157]. Here, ENG is linked to cancer.